Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0X4IV
|
|||
| Former ID |
DIB006285
|
|||
| Drug Name |
PSD-508
|
|||
| Synonyms |
M-5003; Dysmenorrhea therapy (intravaginal), Metris/Plethora; Intravaginal NSAID (dysmenorrhea), Plethora Solutions/Metris
Click to Show/Hide
|
|||
| Indication | Dysmenorrhea [ICD-11: GA34.3; ICD-9: 625.3] | Discontinued in Phase 2 | [1] | |
| Company |
Metris Therapeutics Ltd
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Prostaglandin G/H synthase (COX) | Target Info | Inhibitor | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800027456) | |||
| REF 2 | CN patent application no. 104797935, A method for prognosis and treatment of cancer metastasis. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.